Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-17-002976

Options or other derivatives

  • SVP, Chief Scientific Officer acquired 160,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Eliasof Scott SVP, Chief Scientific Officer 2017-01-05 Grant or award · Stock Option (right to buy) +60,000 60,000 D
Eliasof Scott SVP, Chief Scientific Officer 2017-01-05 Grant or award · Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…